Evidence map›Paper›PMID 31995564›Full record

ArticlePLoS neglected tropical diseases2020

Male predominance in reported Visceral Leishmaniasis cases: Nature or nurture? A comparison of population-based with health facility-reported data.

Kristien Cloots, Sakib Burza, Paritosh Malaviya, Epco Hasker, Sangeeta Kansal, Guy Mollett, Jaya Chakravarty, Nurpur Roy, Bibek Kumar Lal, Suman Rijal and 2 more

Open access · goldAbstract read
In one paragraph

Article in PLoS neglected tropical diseases, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 36 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
36citing papers in PubMed, 3 pooled it
5.9field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

36 citing papers in PubMed, 3 syntheses or guidelines pooled it, 61 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Article
  5. Article
  6. Review
  7. Article
  8. Review
  9. Leishmaniasis.Nature reviews. Disease primers · 2025
    Review
  10. Article
  11. Article
  12. Review
  13. Article
  14. Article
  15. The conneXion between sex and immune responses.Nature reviews. Immunology · 2024
    Review
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 6 institutions in 4 countries.

Kristien ClootsDepartment of Public Health, Institute of Tropical Medicine, Antwerp, Belgium.ORCID 0000-0003-4789-7954
Sakib BurzaMédecins Sans Frontières, New Delhi, India.
Paritosh MalaviyaDepartment of Medicine, Banaras Hindu University, Varanasi, India.
Epco HaskerDepartment of Public Health, Institute of Tropical Medicine, Antwerp, Belgium.
Sangeeta KansalDepartment of Medicine, Banaras Hindu University, Varanasi, India.
Guy MollettFaculty of Infectious and Tropical Diseases, London School of Hygiene and Tropical Medicine, London, United Kingdom.
Jaya ChakravartyDepartment of Medicine, Banaras Hindu University, Varanasi, India.
Nurpur RoyNational Vector Borne Disease Control Program, Ministry of Health & Family Welfare, New Delhi, India.
Bibek Kumar LalEpidemiology and Disease Control Division, Ministry of Health, Kathmandu, Nepal.
Suman RijalDrugs for Neglected Diseases initiative, New Delhi, India.
Shyam SundarDepartment of Medicine, Banaras Hindu University, Varanasi, India.
Marleen BoelaertDepartment of Public Health, Institute of Tropical Medicine, Antwerp, Belgium.
Banaras Hindu University · INInstituut voor Tropische Geneeskunde · BEDrugs for Neglected Diseases Initiative India · INLondon School of Hygiene & Tropical Medicine · GBMinistry of Health and Family Welfare · INMinistry of Health and Population · NP

Funding

Visceral Leishmaniasis in Bihar State, IndiaP50AI074321 · NIAID · BANARAS HINDU UNIVERSITY · PI SUNDAR, SHYAM · 2007 to 2016
$6.4M
NIAID NIH HHS P50 AI074321
6 · The paper itself

Abstract

backgroundBangladesh, India, and Nepal aim for the elimination of Visceral Leishmaniasis (VL), a systemic parasitic infectious disease, as a public health problem by 2020. For decades, male patients have comprised the majority of reported VL cases in this region. By comparing this reported VL sex ratio to the one observed in population-based studies conducted in the Indian subcontinent, we tested the working hypothesis that mainly socio-cultural gender differences in healthcare-seeking behavior explain this gender imbalance. METHODOLOGY/PRINCIPAL

findingsWe compared the observed sex ratio of male versus female among all VL cases reported by the health system in Nepal and in the two most endemic states in India with that observed in population-based cohort studies in India and Nepal. Also, we assessed male sex as a potential risk factor for seroprevalence at baseline, seroconversion, and VL incidence in the same population-based data. The male/female ratio among VL cases reported by the health systems was 1.40 (95% CI 1.37-1.43). In the population cohort data, the age- and study site-adjusted male to female risk ratio was 1.27 (95% CI 1.08-1.51). Also, males had a 19% higher chance of being seropositive at baseline in the population surveys (RR 1.19; 95% CI 1.11-1.27), while we observed no significant difference in seroconversion rate between both sexes at the DAT cut-off titer defined as the primary endpoint. CONCLUSIONS/SIGNIFICANCE: Our population-based data show that male sex is a risk factor for VL, and not only as a socio-cultural determinant. Biological sex-related differences likely play an important role in the pathogenesis of this disease.

Indexed as

AdolescentAdultChildChild, PreschoolDisease NotificationFemaleHealth FacilitiesHumansIncidenceInfantLeishmaniasis, VisceralMaleMiddle AgedSeroepidemiologic StudiesSex RatioYoung Adult

Identifiers

PMID31995564
PMCPMC7010295
OpenAlexW3003636929

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.